Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.47 |
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7704863 | 1.00 | HSD17B1 (0.47) | HSD17B1ESR1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL1249511 | 0.84 | HSD17B1 (0.65) | HSD17B1ESR1LMNAMAPK1PGR | |
| SCHEMBL1981989 | 0.82 | HSD17B1 (0.71) | HSD17B1ESR1LMNASMN1; SMN2ADORA3 | |
| SCHEMBL1246985 | 0.82 | LMNA (0.67) | HSD17B1ESR1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL4284331 | 0.82 | LMNA (0.67) | HSD17B1ESR1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL12379608 | 0.82 | HSD17B1 (0.71) | HSD17B1ESR1LMNASMN1; SMN2ADORA3 | |
| SCHEMBL7707677 | 0.81 | ESR1 (0.48) | ESR1LMNAMAPK1SMN1; SMN2ADORA3 | |
| SCHEMBL6899294 | 0.81 | ESR1 (0.48) | ESR1LMNAMAPK1SMN1; SMN2ADORA3 | |
| SCHEMBL14094306 | 0.81 | LMNA (0.72) | HSD17B1ESR1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL2838564 | 0.81 | HSD17B1 (0.58) | HSD17B1ESR1LMNAMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100111896-A1 | Items Containing A Human Pheromone Component | MARENBERG BARRY J | 2010-05-06 | — | — | US | disclosed |
| WO-2007062023-A2 | ITEMS CONTAINING A HUMAN PHEROMONE COMPONENT | BRAGINSKY PHILIP Y (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-0891188-A4 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARM INC (US) | 2004-09-01 | — | — | EP | disclosed |
| US-6352980-B1 | ADMINISTERING BY SPRAYING IN NOSE | PHERIN PHARMACEUTICALS, INC. | 2002-03-05 | — | — | US | disclosed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-6066627-A | ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE | PHERIN CORPORATION (US) | 2000-05-23 | — | — | US | disclosed |
| US-6057439-A | EPOXYSTEROIDS | PHERIN CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0783513-A4 | NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN CORP (US) | 2000-03-08 | — | — | EP | disclosed |
| US-5994568-A | BIND TO NEUROEPITHELIAL RECEPTORS. | PHERIN CORPORATION (US) | 1999-11-30 | — | — | US | disclosed |
| US-5939570-A | Estrenes for inducing hypothalamic effects | PHERIN CORPORATION (US) | 1999-08-17 | — | — | US | disclosed |
| US-5925774-A | ESTRENE STEROIDS WHICH BIND TO NEUROEPITHELIAL RECEPTORS | PHERIN CORPORATION (US) | 1999-07-20 | — | — | US | disclosed |
| EP-0924219-A2 | Novel estrenes for inducing hypothalamic effects | PHERIN CORPORATION (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0891188-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | Pherin Pharmaceuticals, Inc. (US) | 1999-01-20 | — | — | EP | disclosed |
| US-5783571-A | SUBSTITUTED TETRAENE STEROIDS FOR CONTROLLING GLANDULAR FUNCTION | PHERIN CORPORATION (US) | 1998-07-21 | — | — | US | disclosed |
| WO-1997036596-A9 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | — | 1997-12-04 | — | — | WO | disclosed |
| WO-1997036596-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARMACEUTICALS, INC. (US) | 1997-10-09 | — | — | WO | disclosed |
| EP-0783513-A1 | NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN CORPORATION (US) | 1997-07-16 | — | — | EP | disclosed |
| US-5633392-A | STIMULANTS FOR AUTONOMIC NERVOUS SYSTEM; NOSE SPRAYING | PHERIN CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| WO-1996010032-A1 | NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN CORPORATION (US) | 1996-04-04 | — | — | WO | disclosed |